(ICTE) Invesco S&P/TSX Composite - Ratings and Ratios
Exchange: TO •
Country: Canada •
Currency: CAD •
Type: Etf •
ISIN: CA46144V1013
Description: ICTE Invesco S&P/TSX Composite
from quarterly Tax Provision
ICTE ETF Overview
Market Cap in USD | 2m |
Category | Canadian Equity |
IPO / Inception | 2022-01-20 |
ICTE ETF Ratings
Growth Rating | 68.7 |
Fundamental | - |
Dividend Rating | 79.7 |
Rel. Strength | 7.94 |
Analysts | - |
Fair Price Momentum | 29.03 CAD |
Fair Price DCF | - |
ICTE Dividends
Dividend Yield 12m | 21.41% |
Yield on Cost 5y | 28.77% |
Annual Growth 5y | 97.74% |
Payout Consistency | 75.0% |
Payout Ratio | % |
ICTE Growth Ratios
Growth Correlation 3m | 96% |
Growth Correlation 12m | 91.5% |
Growth Correlation 5y | 81% |
CAGR 5y | 10.09% |
CAGR/Max DD 5y | 0.60 |
Sharpe Ratio 12m | -0.34 |
Alpha | 23.66 |
Beta | 0.134 |
Volatility | 28.89% |
Current Volume | 0.2k |
Average Volume 20d | 0.2k |
Stop Loss | 20.4 (-3.4%) |
What is the price of ICTE shares?
As of August 14, 2025, the stock is trading at CAD 21.12 with a total of 156 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +2.38%, over three months by +8.81% and over the past year by +30.25%.
Over the past week, the price has changed by +0.96%, over one month by +2.38%, over three months by +8.81% and over the past year by +30.25%.
Is Invesco S&P/TSX Composite a good stock to buy?
Yes. Based on ValueRay's Analyses, Invesco S&P/TSX Composite (TO:ICTE) is currently (August 2025)
a good stock to buy. It has a ValueRay Growth Rating of 68.70 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICTE is around 29.03 CAD . This means that ICTE is currently undervalued and has a potential upside of +37.45% (Margin of Safety).
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICTE is around 29.03 CAD . This means that ICTE is currently undervalued and has a potential upside of +37.45% (Margin of Safety).
Is ICTE a buy, sell or hold?
Invesco S&P/TSX Composite has no consensus analysts rating.
What are the forecasts/targets for the ICTE price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.8 | 50.5% |
ICTE Fundamental Data Overview
Market Cap USD = 1.51m (2.07m CAD * 0.7268 CAD.USD)
Market Cap CAD = 2.07m (2.07m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 0.98
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.07m CAD (2.07m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 2.07m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.07m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(2.07m)/V(0.0) * Re(6.51%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Market Cap CAD = 2.07m (2.07m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 0.98
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.07m CAD (2.07m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 2.07m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.07m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(2.07m)/V(0.0) * Re(6.51%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)